SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3559 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2357Yes, Dupi prospert is next to Eylea, and as market report here, it is almost as Miljenko Zuanic-3/19/2018
2356The market is yawning at REGN, or worse. The rallies get sold quickly. Just caBiotech Jim-3/19/2018
2355As visible in this table, E WW sale for 2022 is $~7B, so where is a problem for Miljenko Zuanic-3/19/2018
2354Next incremental step in Eylea growth, T2D prevalence continuously increase so dMiljenko Zuanic-3/19/2018
2353Interesting read on Praluent v Repatha IP litigation: markmanadvisors.com I amMiljenko Zuanic-3/16/2018
2352ORR were too small to point toward meaningful clinical benefit (relative to costMiljenko Zuanic-3/15/2018
2351Why the surprise re ORR endpoint? Accelerated-approval BLAs based on ORR (as in DewDiligence_on_SI-3/15/2018
2350Cervical cancer, HPV associated: REGN2810 for platinum-refractory cervical cancMiljenko Zuanic-3/15/2018
2349In general, Bloomberg's biotech writers (especially Max Nisen) tend to be unDewDiligence_on_SI13/12/2018
2348finance.yahoo.com Mr. Market and Honorable Analysts do not agree with SchleiferMiljenko Zuanic-3/12/2018
2347Clearly someone that Bloomberg doesn't like REGN or they are paidFelix B-3/10/2018
2346Bloomberg is the only one who call trial data disappointment: bloomberg.com WeMiljenko Zuanic-3/10/2018
2345<Hallelujah!> Indeed, it is finally over. Regardless what individual thinMiljenko Zuanic-3/10/2018
2344Here is the pdf of the CC slide show. 87788.choruscall.eu Hallelujah!Biotech Jim-3/10/2018
2343Regeneron achieved modest victory with Odyssey: globenewswire.com and with newMiljenko Zuanic13/10/2018
2342OT AMZN: seekingalpha.com In addition to many "disrupting" categorieMiljenko Zuanic-3/9/2018
2341Orlando live, but no news: investor.regeneron.comMiljenko Zuanic-3/9/2018
2340In Ireland, they are not slowing down: independent.ie What is wrong with RensseMiljenko Zuanic-3/9/2018
2339nih.gov nih.gov Abs and emerging infectious diseases, it may be sort of opportuMiljenko Zuanic-3/8/2018
2338Saturday afternoon/early evening, with investigators on board. Or Monday morninMiljenko Zuanic-3/6/2018
2337So you are expecting a flop from REGN? Although couldn't they have a CC MonFelix B-3/6/2018
2336Bill Sibold (from Sanofi Genzyme) is presenting at Coven-Boston on 3-12, 1:30 pMiljenko Zuanic-3/5/2018
2335Unblinding the data is one thing, unblinding the 'results' are another! Miljenko Zuanic-3/5/2018
2334Just all the negative press is why I am surprised its not moving down and curiouFelix B-3/2/2018
2333Why? There was no harm to Eylea US sale for jan-feb period, and there was not atMiljenko Zuanic-3/2/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News